title: EORTC/CRC/NCI guidelines for the formulation of investigational cytotoxic drugs.
authors.affiliation: Pharmaceutical Resources Branch, National Cancer Institute, Bethesda, MD.
authors.forename: J P
authors.initials: JP
authors.lastname: Davignon
authors.forename: J A
authors.initials: JA
authors.lastname: Slack
authors.forename: J H
authors.initials: JH
authors.lastname: Beijnen
authors.forename: W R
authors.initials: WR
authors.lastname: Vezin
authors.forename: T J
authors.initials: TJ
authors.lastname: Schoemaker
mesh_terms: D000970:Antineoplastic Agents; D002626:Chemistry, Pharmaceutical; D004341:Drug Evaluation; D004349:Drug Packaging; D004355:Drug Stability; D004356:Drug Storage
chemical_list: D000970:Antineoplastic Agents